TRIENTINE-REDDY'S trientine dihydrochloride 250 mg capsule bottle

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

trientine dihydrochloride

Commercializzato da:

Dr Reddys Laboratories Australia Pty Ltd

Forma farmaceutica:

Capsule

Composizione:

Excipient Ingredients: iron oxide yellow; titanium dioxide; Gelatin; magnesium stearate; purified water; macrogol 3350; colloidal anhydrous silica

Via di somministrazione:

Oral

Confezione:

100

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Trientine dihydrochloride capsules are indicated for the treatment of patients with Wilson's disease who are intolerant of penicillamine.

Dettagli prodotto:

Visual Identification: Yellow opaque, hard gelatin size 1 capsules imprinted with RDY on cap and 459 on body in black ink filled with white to pale yellow powder.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2021-03-29